News
Children with SCD who have sleep issues, such as sustained low blood oxygen during sleep, require more healthcare resources, ...
Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).
The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...
Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.
A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...
The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of carbon monoxide.
The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and Puerto Rico, have agreed to participate in the Cell and Gene Therapy (CGT) ...
Columnist Tito Oye struggles to describe the pain involved in a sickle cell crisis. She turns to social media to ask her followers for help.
The blood-separation device Spectra Optia, which has the ability to remove abnormal red blood cells from sickle cell patients, can efficiently and safely replace these cells with healthy red blood ...
Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell disease, a study reports.
Clinton Health Access Initiative will use award to expand access to SCD diagnostic tests and treatment in low- and middle-income countries.
Suburban Propane, the American Red Cross and others honored Charles R. Drew, a pioneer in blood transfusions, to address sickle cell disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results